BioSpace News Archive

Biotech Bay

Twist Bioscience Launches Mouse Exome to Power Genetic Research

Twist Mouse Core Exome Panel is the most comprehensive, up-to-date tool for interrogation of the mouse exome, further enabling genetic research of this important model organism.

June 17, 2019
·
2 min read
Job Trends

GT Medical Technologies Announces Presentation of Data Demonstrating the Safety Profile of GammaTile Therapy for Various Brain Tumors

Company Co-Founder and Chief Technology Officer Receives Distinguished Judith Stitt Best Abstract Award for Data Presented at the American Brachytherapy Society Annual Meeting

June 17, 2019
·
4 min read
Business

Novo Nordisk Canada Joins BioTalent Canada National Partnership Network

The partnership is a perfect fit for two organizations who take pride in empowering their employees to make a difference in Canada’s bio-economy.

June 17, 2019
·
2 min read
Business

Ventas Named as a Founding Partner of The Global Institute on Innovation Districts

Today, by conservative estimates, there are more than 100 innovation districts emerging around the world.

June 17, 2019
·
4 min read
BioMidwest

Ventas Announces $0.8 Billion in New University-Based Research & Innovation Developments

Four New Research, Academic and Innovation Projects With Current and New University Relationships Including University of Pittsburgh and Drexel University

June 17, 2019
·
16 min read
Job Trends

Ampio Pharmaceuticals Announces Pricing of Public Offering

Ampio anticipates an additional 4,680,000 shares of its Common Stock will be sold at the same price at the close of the offering.

June 17, 2019
·
3 min read
China Jo-Jo Drugstores Hosts Reception of the Prime Minister of PRC

China Jo-Jo Drugstores, Inc. announced that the Company hosted a reception for Mr. Li Keqiang, the Prime Minister of the People’s Republic of China on June 12, 2019.

June 17, 2019
·
3 min read
Drug Development

Arena Pharmaceuticals Announces First Subject Dosed in ELEVATE UC 52 Global Phase 3 Trial Evaluating Etrasimod in Ulcerative Colitis

Arena Pharmaceuticals, Inc. announced that the first subject has been dosed in ELEVATE UC 52, the first of two pivotal trials within the Phase 3 ELEVATE UC registrational program evaluating etrasimod 2 mg in subjects with moderately to severely active ulcerative colitis.

June 17, 2019
·
7 min read
Drug Development

NuVasive Expands Advanced Materials Science™ Portfolio with Launch of Porous Titanium Spine Implant for Transforaminal Lumbar Interbody Fusion

NuVasive, Inc. announced the commercial launch of Modulus® TLIF-O, a porous titanium spine implant engineered for the transforaminal lumbar interbody fusion procedure.

June 17, 2019
·
5 min read
Business

OncoSec Announces Research Collaboration with Roswell Park Comprehensive Cancer Center Using Cutting-Edge Intravital Microscopy (IVM), TAVO-PLUS and APOLLO™ Electroporation Generator

IVM is a powerful tool enabling real-time in vivo visualization of important immune activation and movements in tumor microenvironment driven by TAVO-PLUS

June 17, 2019
·
4 min read